The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
SLEEP 2026 | Advances in clinical management of sleep apnea: KPAP, GLP-1 agonists, & more
Omonigho Michael Bubu, MD, MPH, PhD, NYU Grossman School of Medicine, New York City, NY, shares highlights from a session at SLEEP 2026 focused on clinical advances in sleep apnea. Dr Bubu highlights advances in Kairos positive airway pressure (KPAP), the management of obesity using GLP-1 agonists, and more. This interview took place at the 40th annual meeting of the Associated Professional Sleep Societies (APSS) in Baltimore, MD.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
